|
1
|
Bruix J, Boix L and Sala M: Focus on
hepatocellular carcinoma. Cancer Cell. 5:215–219. 2004. View Article : Google Scholar
|
|
2
|
Tang ZY: Hepatocellular carcinoma – cause,
treatment and metastasis. World J Gastroenterol. 7:445–454.
2001.
|
|
3
|
Kim W, Gores G, Benson JT, Therneau TM and
Melton LJ III: Mortality and hospital utilization for
hepatocellular carcinoma in the United States. Gastroenterology.
129:486–493. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen CH, Chen GL, Lee HS and Huang GT:
Expressions of cancer-testis antigens in human hepatocellular
carcinomas. Cancer Lett. 164:189–195. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chomez P, De Backer O and Bertrand M: An
overview of the MAGE gene family with the identification of all
human members of the family. Cancer Res. 61:5544–5551.
2001.PubMed/NCBI
|
|
6
|
Luo G, Huang S and Xie X: Expression of
cancer-testis genes in human hepatocellular carcinomas. Cancer
Immunity. 2:11–21. 2002.PubMed/NCBI
|
|
7
|
Peng JR, Chen HS and Mou DC: Expression of
cancer/testis (CT) antigens in Chinese hepatocellular carcinoma and
its correlation with clinical parameters. Cancer Lett. 219:223–232.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tajima K, Obata Y and Tamaki H: Expression
of cancer/testis (CT) antigens in lung cancer. Lung Cancer.
42:23–33. 2003. View Article : Google Scholar
|
|
9
|
Caballero OL and Chen YT: Cancer/testis
(CT) antigens: potential targets for immunotherapy. Cancer Sci.
100:2014–2021. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brinkmann U, Vasmatzis G and Lee B: Novel
genes in the PAGE and GAGE family of tumor antigens found by
homology walking in the dbEST database. Cancer Res. 59:1445–1448.
1999.PubMed/NCBI
|
|
11
|
Liu XF, Helman LJ and Yeung C: XAGE-1, a
new gene that is frequently expressed in Ewing’s sarcoma. Cancer
Res. 60:4752–4755. 2000.PubMed/NCBI
|
|
12
|
Zendman AJ, van Kraats AA and den
Hollander AI: Characterization of XAGE-1b, a short major transcript
of cancer/testis-associated gene XAGE-1, induced in melanoma
metastasis. Int J Cancer. 97:195–204. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zendman AJ, van Kraats AA and Weidle UH:
The XAGE family of cancer/testis-associated genes: alignment and
expression profile in normal tissues, melanoma lesions and Ewing’s
sarcoma. Int J Cancer. 99:361–369. 2002.PubMed/NCBI
|
|
14
|
Egland KA, Kumar V and Duray P:
Characterization of overlapping XAGE-1 transcripts encoding a
cancer testis antigen expressed in lung, breast, and other types of
cancers. Mol Cancer Ther. 1:441–450. 2002.PubMed/NCBI
|
|
15
|
Jun HL, Sang PK and Edward G: Activation
of human cancer/testis antigen gene, XAGE-1, in tumor cells is
correlated with CpG island hypomethylation. Int J Cancer.
116:200–206. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sato S, Noguchi Y and Ohara N:
Identification of XAGE-1 isoforms: predominant expression of
XAGE-1b in testis and tumors. Cancer Immunity. 7:5–12.
2007.PubMed/NCBI
|
|
17
|
Alsoe L, Stacy JE and Fossa A:
Identification of prostate cancer antigens by automated
high-throughput filter immunoscreening. J Immunol Methods.
330:12–23. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fossa A, Alsoe L and Crameri R:
Serological cloning of cancer/testis antigens expressed in prostate
cancer using cDNA phage surface display. Cancer Immunol Immunother.
53:431–438. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ali Eldib AM, Ono T and Shimono M:
Immunoscreening of a cDNA library from a lung cancer cell line
using autologous patient serum: identification of XAGE-1b as a
dominant antigen and its immunogenicity in lung adenocarcinoma. Int
J Cancer. 108:558–563. 2004.PubMed/NCBI
|
|
20
|
James SR, Link PA and Karpf AR: Epigenetic
regulation of X-linked cancer/germline antigen genes by DNMT1 and
DNMT3b. Oncogene. 25:6975–6985. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gjerstorff M, Burns JS and Nielsen O:
Epigenetic modulation of cancer-germline antigen gene expression in
tumorigenic human mesenchymal stem cells: implications for cancer
therapy. Am J Pathol. 175:314–323. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Koizumi F, Noguchi Y and Saika T: XAGE-1
mRNA expression in prostate cancer and antibody response in
patients. Microbiol Immunol. 49:471–476. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nakagawa K, Noguchi Y and Uenaka A: XAGE-1
expression in non-small cell lung cancer and antibody response in
patients. Clin Cancer Res. 11:5496–5503. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Watanabe Y and LePage S: Characterization
of preexisting humoral immunity specific for two cancer-testis
antigens overexpressed at the mRNA level in non-small cell lung
cancer. Cancer Immunity. 6:3–11. 2006.PubMed/NCBI
|
|
25
|
Wang T, Fan L and Watanabe Y: L552S, an
alternatively spliced isoform of XAGE-1, is overexpressed in lung
adenocarcinoma. Oncogene. 20:7699–7709. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Morishita Y, Uenaka A and Kaya S:
HLA-DRB1*0410-restricted recognition of XAGE-1b 37-48
peptide by CD4 T cells. Microbiol Immunol. 51:755–762. 2007.
|
|
27
|
Shimono M, Uenaka A and Noguchi Y:
Identification of DR9-restricted XAGE antigen on lung
adenocarcinoma recognized by autologous CD4 T-cells. Int J Oncol.
30:835–840. 2007.PubMed/NCBI
|
|
28
|
Kikuchi E, Yamazaki K and Nakayama E:
Prolonged survival of patients with lung adenocarcinoma expressing
XAGE-1b and HLA class I antigens. Cancer Immunity. 8:13–18.
2008.PubMed/NCBI
|
|
29
|
Zhou Q, Guo AL and Xu CR: A dendritic
cell-based tumour vaccine for lung cancer: full-length XAGE-1b
protein-pulsed dendritic cells induce specific cytotoxic T
lymphocytes in vitro. Clin Exp Immunol. 153:392–400. 2008.
View Article : Google Scholar : PubMed/NCBI
|
